Edition:
United Kingdom

BioDelivery Sciences International Inc (BDSI.OQ)

BDSI.OQ on NASDAQ Stock Exchange Capital Market

2.80USD
8:59pm GMT
Change (% chg)

$0.10 (+3.70%)
Prev Close
$2.70
Open
$2.75
Day's High
$2.95
Day's Low
$2.70
Volume
401,896
Avg. Vol
70,172
52-wk High
$3.60
52-wk Low
$1.58

Select another date:

Thu, Dec 14 2017

BRIEF-BioDelivery Sciences Reacquires Onsolis From Collegium Pharmaceutical

* BIODELIVERY SCIENCES REACQUIRES ONSOLIS® FROM COLLEGIUM PHARMACEUTICAL

BRIEF-BioDelivery Sciences Says ‍Ohio Workers Compensation Approved Change To Formulary

* BIODELIVERY SCIENCES - ‍OHIO BUREAU OF WORKERS COMPENSATION APPROVED CHANGE TO ITS FORMULARY RESULTING IN FAVORABLE POSITIONING FOR BELBUCA, BUNAVAIL

BRIEF-BioDelivery Sciences reports Q3 loss per share $0.21

* BioDelivery Sciences reports third quarter 2017 financial results and provides corporate update

BRIEF-BioDelivery sciences announces patent litigation settlement agreement with Teva

* BioDelivery Sciences announces patent litigation settlement agreement with Teva

BRIEF-BioDelivery Sciences CEO Mark Sirgo to retire

* BioDelivery Sciences president and chief executive officer Mark Sirgo to retire at year-end while continuing as vice chairman

BRIEF-BioDelivery Sciences reports Q2 loss per share $0.27

* BioDelivery Sciences reports second quarter 2017 financial results and provides corporate update

BRIEF-Biodelivery Sciences signs agreement with Purdue Pharma

* Biodelivery Sciences signs exclusive agreement with Purdue Pharma (Canada) for the licensing and distribution rights of Belbuca in Canada

BRIEF-Biodelivery Sciences announces Health Canada approval of Belbuca

* Biodelivery Sciences announces Health Canada approval of Belbuca®

BRIEF-BioDelivery Sciences announces agreement with CVS/Caremark for Belbuca, Bunavail

* BioDelivery Sciences announces agreement with CVS/Caremark for Belbuca® and Bunavail® through 2020

Select another date: